These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17949714)

  • 1. A regulatory perspective on the development of gene therapy for Parkinson's disease.
    Havert MB
    Exp Neurol; 2008 Jan; 209(1):48-50. PubMed ID: 17949714
    [No Abstract]   [Full Text] [Related]  

  • 2. Special focus section: gene therapy for Parkinson's disease.
    Fiske BK; Frasier MA; Sherer TB
    Exp Neurol; 2008 Jan; 209(1):28-9. PubMed ID: 17980867
    [No Abstract]   [Full Text] [Related]  

  • 3. Gene therapy for Parkinson's disease: current knowledge and future perspective.
    Mouradian MM; Chase TN
    Gene Ther; 1997 Jun; 4(6):504-6. PubMed ID: 9231065
    [No Abstract]   [Full Text] [Related]  

  • 4. The need for regulatable vectors for gene therapy for Parkinson's disease.
    Cress DE
    Exp Neurol; 2008 Jan; 209(1):30-3. PubMed ID: 17942096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral vectors, animal models and new therapies for Parkinson's disease.
    Schneider B; Zufferey R; Aebischer P
    Parkinsonism Relat Disord; 2008; 14 Suppl 2():S169-71. PubMed ID: 18585946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo gene delivery for development of mammalian models for Parkinson's disease.
    Ulusoy A; Bjorklund T; Hermening S; Kirik D
    Exp Neurol; 2008 Jan; 209(1):89-100. PubMed ID: 18028909
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene therapy for Parkinson's disease shows promise.
    Björklund A; Björklund T
    Sci Transl Med; 2011 Apr; 3(79):79ed1. PubMed ID: 21508307
    [No Abstract]   [Full Text] [Related]  

  • 8. Issues regarding gene therapy products for Parkinson's disease: the development of CERE-120 (AAV-NTN) as one reference point.
    Bartus RT; Herzog CD; Bishop K; Ostrove JM; Tuszynski M; Kordower JH; Gasmi M
    Parkinsonism Relat Disord; 2007; 13 Suppl 3():S469-77. PubMed ID: 18267286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDA approval allows gene therapy in Japan.
    Swinbanks D
    Nature; 1995 Jul; 376(6537):202. PubMed ID: 7617018
    [No Abstract]   [Full Text] [Related]  

  • 10. Gene therapists promise renewed vigor in monitoring as field progresses.
    SoRelle R
    Circulation; 2001 Jan; 103(1):E9001-2. PubMed ID: 11136706
    [No Abstract]   [Full Text] [Related]  

  • 11. [Gene therapy for Parkinson's disease].
    Gómez Gallego M; Fernández Barreiro A
    Neurologia; 2007; 22(1):27-38. PubMed ID: 17315100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emerging restorative treatments for Parkinson's disease.
    Deierborg T; Soulet D; Roybon L; Hall V; Brundin P
    Prog Neurobiol; 2008 Aug; 85(4):407-32. PubMed ID: 18586376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RNA interference: a critical analysis of the regulatory and ethical issues encountered in the development of a novel therapy.
    McKnight R
    Albany Law J Sci Technol; 2004; 15(1):73-108. PubMed ID: 17340758
    [No Abstract]   [Full Text] [Related]  

  • 14. Expanded use of brain implant for Parkinson's disease.
    FDA Consum; 2002; 36(2):4. PubMed ID: 11989470
    [No Abstract]   [Full Text] [Related]  

  • 15. Gene therapy experiments put on "clinical hold".
    Ciment J
    BMJ; 2000 Feb; 320(7231):336. PubMed ID: 10657323
    [No Abstract]   [Full Text] [Related]  

  • 16. Positive clinical data in Parkinson's and ischemia buoy gene therapy.
    Sheridan C
    Nat Biotechnol; 2007 Aug; 25(8):823-4. PubMed ID: 17687344
    [No Abstract]   [Full Text] [Related]  

  • 17. First treatment for dementia of Parkinson's disease.
    FDA Consum; 2006; 40(5):5. PubMed ID: 17328100
    [No Abstract]   [Full Text] [Related]  

  • 18. New measures introduced to monitor gene therapy trials.
    Hollon T
    Nat Med; 2000 May; 6(5):486. PubMed ID: 10802682
    [No Abstract]   [Full Text] [Related]  

  • 19. FDA regulation: an answer to the questions of human cloning and germline gene therapy.
    Willgoos C
    Am J Law Med; 2001; 27(1):101-24. PubMed ID: 11367820
    [No Abstract]   [Full Text] [Related]  

  • 20. Regulation of somatic-cell therapy and gene therapy by the food and drug administration.
    Kessler DA; Siegel JP; Noguchi PD; Zoon KC; Feiden KL; Woodcock J
    N Engl J Med; 1993 Oct; 329(16):1169-73. PubMed ID: 8377782
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.